Share this
therapeutic drug monitoring immunosuppressants: microsampling benefits
by Neoteryx on Jan 14, 2020 4:43:00 AM
Therapeutic drug monitoring (TDM) of immunosuppressants is a critical component of post-tissue and organ transplantation therapy. This is because ISP drugs have high intra- and inter-subject variability and a narrow therapeutic window. Traditionally, quantitative analysis of ISPs such as tacrolimus, sirolimus, cyclosporine A, and everolimus has used whole blood specimens.
However, wet samples present several disadvantages for TDM, including a weak correlation with drug concentrations at the place of action and poor prediction of allograft toxicity and survival. Additionally, the methods used to obtain wet blood samples are somewhat invasive, requiring a phlebotomist to insert a needle into a vein to draw tubes of wet blood.
Sampling Methods for TDM
Alternative blood collection methods have since been developed – capillary blood microsampling from a simple finger-stick, for example – and the collected microsamples arrive in the lab for analysis as dried blood samples. One analytical method for processing and analyzing these samples in the laboratory is LC-MS/MS. It allows researchers to measure drug concentrations in small sample volumes with adequate selectivity, sensitivity, and robustness.
The main challenge of the LC/MS/MS method is the matrix effect, which can produce erroneous results. Clinical researchers suggest cleaning samples and using deuterated IS to mitigate this effect.
Another sampling method for TDM of ISPs has also been introduced, including the use of oral fluids, but it is also bound to produce erroneous results. This is because fluid samples are prone to contamination.
Dried blood spot (DBS) sampling onto filter paper was the next alternative to traditional whole blood sampling, as well as plasma, and serum sampling for TDM. However, research shows ISP concentration on DBS cards and filter paper varies due to the hematocrit effect, among other factors.
Volumetric Microsampling
A more advanced microsampling technique was developed called "volumetric microsampling" and "volumetric absorptive microsampling." Hematocrit effects do not influence the sample quality in the same way as they did previous outdated dried blood spot technologies such as DBS cards and filter paper. Volumetric microsampling uses a portable device to collect the samples from a finger-stick. The micro-sized blood sample is drawn using the tip of the device, with technology proven to collect consistent blood volume independent of hematocrit.
Volumetric Absorptive Microsampling: Mitra
One such device is the Mitra® device based on VAMS® technology. The Mitra's VAMS tip has a porous synthetic material that is designed to absorb a few drops of blood through capillary action when the tip comes into contact with the fluid. The tip absorbs the accurate volume of blood in seconds. The blood will air dry on the tip of the device, which can be mailed to the lab for analysis. Once in the lab, the dried VAMS tips are removed from the Mitra microsamplers for the extraction of the analyte.
Volumetric Microsampling with Precision DBS: hemaPEN
Another portable microsampling device is the hemaPEN® based on a combination of capillary blood sampling and DBS sampling. The hemaPEN collects 4 volumetrically identical capillary samples from a single finger-stick. The 4 capillaries rapidly draw the blood samples and transfer them inside the hemaPEN onto an internal cartridge containing 4 separate DBS filter cards. The volume of the 4 DBS samples is identical and precise. As soon as the end-user clicks the sampled "pen" into its plastic cap (base), the "pen" shuts with tamper resistance and the 4 DBS samples are locked inside until lab processing.
Both of these microsampling devices are well-suited for TDM programs that enable either a patient at home to self-collect their samples and mail them to the lab for analysis, or a healthcare professional to visit patients at home to perform the remote microsampling. In either scenario, the patient is relieved of the burden of making frequent trips to the clinic or lab for painful blood draws to monitor their drug levels. With remote TDM, the care team is able to efficiently monitor the patients drug concentration levels without interruption and with reliable data.
Microsampling-based TDM allows accurate monitoring of ISP concentrations and offers potential advantages compared to traditional sample collection methods.
A real advantage of microsampling, as many research and medical centers learned during the COVID-19 Pandemic, is that it offers the possibility of home sampling and remote patient monitoring. This feature presents many advantages to bedridden patients and those living in remote areas.
A Note to Researchers and Clinicians: Adequate patient training is necessary for optimum sample collection in remote settings. Also, proper sample handling and storage after collection is critical to ensure the stability of results. The Neoteryx microsampling team at Trajan Scientific and Medical provides resources and support to ensure that your cohorts receive the instructions and training they need to collect high-quality samples at home for accurate therapeutic drug monitoring.
Visit our Resources tab to find the instructions, videos and other resources you need for Mitra devices and hemaPEN devices.
To get your initial questions about microsampling answered, please visit our Frequently Asked Questions.
For case studies and peer-reviewed publications and other resources, please visit our Technical Resource Library.
Image credits: Trajan, Neoteryx, iStock
Share this
- Venipuncture Alternative (109)
- Clinical Trials, Clinical Research (69)
- Mitra® Device (44)
- Research, Remote Research (37)
- Dried Blood Spot, DBS (32)
- Therapeutic Drug Monitoring, TDM (16)
- Decentralized Clinical Trial (DCT) (12)
- Blood Microsampling, Serology (10)
- Infectious Disease, Vaccines, COVID-19 (10)
- Microsampling (9)
- hemaPEN® Device (7)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (6)
- Pharmaceuticals, Drug Development (5)
- Harpera® Tool (4)
- Omics, Multi-Omics (4)
- Skin Microsampling, Microbiopsy (4)
- Antibodies, MAbs (3)
- Biomonitoring, Health, Wellness (3)
- Preclinical Research, Animal Studies (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (6)
- October 2019 (4)
- September 2019 (5)
- August 2019 (5)
- July 2019 (4)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (6)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (8)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (5)
- February 2018 (7)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
No Comments Yet
Let us know what you think